Posts

Chapel Hill - Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th Public Library of Science.

Chapel Hill - When cancer patients experience medical problems, they may visit emergency departments, but how often and for what reasons, there is little data.

A University of North Carolina at Chapel Hill study has joined the ranks of an elite group of programs recognized for their contributions to reducing cancer.

Innovative collaboration between physics and cell biology demonstrates pathway

C.A.R.E. (Cancer - Awareness - Responsibility - Education) Behind the Chair : An Informative Event for Melanoma Awareness Month

Richard Goldberg, MD, distinguished professor and chief of the division of hematology/oncology, has been appointed to chair the 2012 Gastrointestinal Cancers Symposium Steering Committee on behalf of the American Society for Clinical Oncology (ASCO).

CHAPEL HILL, N.C. – Dr. Carolyn Sartor discussed the “New Life After Cancer” organization on the April 28, 2011 broadcast of Here's to Your Health. Dr. Sartor is a breast cancer survivor and former Chair of Radiation Oncology at UNC.

The 35th annual UNC Lineberger scientific symposium attracted more than 530 participants. Held at the Friday Center on April 27-28, 2011, the event featured speakers on "Cell Metabolism and Cancer."

NCCU-UNC Lineberger scientific collaboration yields new findings

Prestigious Executive Leadership in Academic Medicine Program builds pipeline of women leaders